Expert Rev Proteomics. 2015 Nov 2:1-15. [Epub ahead of print]

Streptococcus pneumoniae proteomics: determinants of pathogenesis and vaccine development.

Bittaye M1, Cash P1.

Author information


Streptococcus pneumoniae is a major pathogen that is responsible for a variety of invasive diseases. The bacteria gain entry initially by establishing a carriage state in the nasopharynx from where they migrate to other sites in the body. The worldwide distribution of the bacteria and the severity of the diseases have led to a significant level of interest in the development of vaccines against the bacteria. Current vaccines, based on the bacterial polysaccharide, have a number of limitations including poor immunogenicity and limited effectiveness against all pneumococcal serotypes. There are many challenges in developing vaccines that will be effective against the diverse range of isolates and serotypes for this highly variable bacterial pathogen. This review considers how proteomic technologies have extended our understanding of the pathogenic mechanisms of nasopharyngeal colonization and disease development as well as the critical areas in developing protein-based vaccines.


Cell wall proteins; Streptococcus pneumoniae; pathogenesis; proteome; vaccines

PMID: 26524107